control group:Irbesartan Tablets

3 trials

Sponsors

Gansu Provincial Hospital of TCM, Ruijin Hospital, The First Hospital of Hunan University of traditional Chinese Medicine

Conditions

Diabetic nephropathyHypertensionIdiopathic membranous nephropathy

Phase 1

To evaluate the efficacy and safety of Tianma xiongling Zhixuan tablet in the treatment of primary hypertension with hyperactivity of liver yang or phlegm and blood stasis syndrome, a

Active, not recruitingITMCTR2200006606

The First Hospital of Hunan University of traditional Chinese MedicineHypertension

Start: 2022-09-16Updated: 2023-02-20

Phase 4

Clinical study on the treatment of diabetic nephropathy by Tangshenkang capsule

RecruitingChiCTR-IPR-17013758

Gansu Provincial Hospital of TCMDiabetic nephropathy

Start: 2017-12-11Updated: 2017-12-11

Prospective multicenter randomized controlled study of efficacy and safety of torch flower root tablet in low-risk idiopathic membranous nephropathy

Active, not recruitingITMCTR2025001621

Ruijin HospitalIdiopathic membranous nephropathy

Start: 2023-11-01Updated: 2025-09-15